BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

2405 related articles for article (PubMed ID: 28622513)

  • 1. Comprehensive and Integrative Genomic Characterization of Hepatocellular Carcinoma.
    ;
    Cell; 2017 Jun; 169(7):1327-1341.e23. PubMed ID: 28622513
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Integrative analysis of aberrant Wnt signaling in hepatitis B virus-related hepatocellular carcinoma.
    Ding SL; Yang ZW; Wang J; Zhang XL; Chen XM; Lu FM
    World J Gastroenterol; 2015 May; 21(20):6317-28. PubMed ID: 26034368
    [TBL] [Abstract][Full Text] [Related]  

  • 3. IDH1 R132C mutation is detected in clear cell hepatocellular carcinoma by pyrosequencing.
    Lee JH; Shin DH; Park WY; Shin N; Kim A; Lee HJ; Kim YK; Choi KU; Kim JY; Yang YI; Lee CH; Sol MY
    World J Surg Oncol; 2017 Apr; 15(1):82. PubMed ID: 28403884
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Integrated genomic analyses of hepatocellular carcinoma.
    Chang YS; Tu SJ; Chen HD; Hsu MH; Chen YC; Chao DS; Chung CC; Chou YP; Chang CM; Lee YT; Yen JC; Jeng LB; Chang JG
    Hepatol Int; 2023 Feb; 17(1):97-111. PubMed ID: 36472800
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Genomic profiling of combined hepatocellular-cholangiocarcinoma reveals similar genetics to hepatocellular carcinoma.
    Joseph NM; Tsokos CG; Umetsu SE; Shain AH; Kelley RK; Onodera C; Bowman S; Talevich E; Ferrell LD; Kakar S; Krings G
    J Pathol; 2019 Jun; 248(2):164-178. PubMed ID: 30690729
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Integrative analysis reveals novel driver genes and molecular subclasses of hepatocellular carcinoma.
    Yang L; Zhang Z; Sun Y; Pang S; Yao Q; Lin P; Cheng J; Li J; Ding G; Hui L; Li Y; Li H
    Aging (Albany NY); 2020 Nov; 12(23):23849-23871. PubMed ID: 33221766
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Accumulation of Molecular Aberrations Distinctive to Hepatocellular Carcinoma Progression.
    Midorikawa Y; Yamamoto S; Tatsuno K; Renard-Guillet C; Tsuji S; Hayashi A; Ueda H; Fukuda S; Fujita T; Katoh H; Ishikawa S; Covington KR; Creighton CJ; Sugitani M; Wheeler DA; Shibata T; Nagae G; Takayama T; Aburatani H
    Cancer Res; 2020 Sep; 80(18):3810-3819. PubMed ID: 32641413
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comprehensive molecular and immunological characterization of hepatocellular carcinoma.
    Shimada S; Mogushi K; Akiyama Y; Furuyama T; Watanabe S; Ogura T; Ogawa K; Ono H; Mitsunori Y; Ban D; Kudo A; Arii S; Tanabe M; Wands JR; Tanaka S
    EBioMedicine; 2019 Feb; 40():457-470. PubMed ID: 30598371
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Identification of hedgehog signaling as a potential oncogenic driver in an aggressive subclass of human hepatocellular carcinoma: A reanalysis of the TCGA cohort.
    Zhao Y; Zhang L; Zhang Y; Meng B; Ying W; Qian X
    Sci China Life Sci; 2019 Nov; 62(11):1481-1491. PubMed ID: 31313086
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical Impact of Genomic Diversity From Early to Advanced Hepatocellular Carcinoma.
    Nault JC; Martin Y; Caruso S; Hirsch TZ; Bayard Q; Calderaro J; Charpy C; Copie-Bergman C; Ziol M; Bioulac-Sage P; Couchy G; Blanc JF; Nahon P; Amaddeo G; Ganne-Carrie N; Morcrette G; Chiche L; Duvoux C; Faivre S; Laurent A; Imbeaud S; Rebouissou S; Llovet JM; Seror O; Letouzé E; Zucman-Rossi J
    Hepatology; 2020 Jan; 71(1):164-182. PubMed ID: 31206197
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Target genes discovery through copy number alteration analysis in human hepatocellular carcinoma.
    Gu DL; Chen YH; Shih JH; Lin CH; Jou YS; Chen CF
    World J Gastroenterol; 2013 Dec; 19(47):8873-9. PubMed ID: 24379610
    [TBL] [Abstract][Full Text] [Related]  

  • 12.
    Anwar SL; Krech T; Hasemeier B; Schipper E; Schweitzer N; Vogel A; Kreipe H; Buurman R; Skawran B; Lehmann U
    World J Gastroenterol; 2017 Mar; 23(9):1568-1575. PubMed ID: 28321157
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Integrative analysis of highly mutated genes in hepatitis B virus-related hepatic carcinoma.
    Kong F; Kong D; Yang X; Yuan D; Zhang N; Hua X; You H; Zheng K; Tang R
    Cancer Med; 2020 Apr; 9(7):2462-2479. PubMed ID: 32017470
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mixed hepatocellular cholangiocarcinoma tumors: Cholangiolocellular carcinoma is a distinct molecular entity.
    Moeini A; Sia D; Zhang Z; Camprecios G; Stueck A; Dong H; Montal R; Torrens L; Martinez-Quetglas I; Fiel MI; Hao K; Villanueva A; Thung SN; Schwartz ME; Llovet JM
    J Hepatol; 2017 May; 66(5):952-961. PubMed ID: 28126467
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Molecular genomic landscapes of hepatobiliary cancer.
    Shibata T; Arai Y; Totoki Y
    Cancer Sci; 2018 May; 109(5):1282-1291. PubMed ID: 29573058
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Characterization of pediatric hepatocellular carcinoma reveals genomic heterogeneity and diverse signaling pathway activation.
    Haines K; Sarabia SF; Alvarez KR; Tomlinson G; Vasudevan SA; Heczey AA; Roy A; Finegold MJ; Parsons DW; Plon SE; López-Terrada D
    Pediatr Blood Cancer; 2019 Jul; 66(7):e27745. PubMed ID: 30977242
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Identification of potential miRNA-mRNA regulatory network contributing to pathogenesis of HBV-related HCC.
    Lou W; Liu J; Ding B; Chen D; Xu L; Ding J; Jiang D; Zhou L; Zheng S; Fan W
    J Transl Med; 2019 Jan; 17(1):7. PubMed ID: 30602391
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Integrative epigenomic and genomic filtering for methylation markers in hepatocellular carcinomas.
    Shen J; LeFave C; Sirosh I; Siegel AB; Tycko B; Santella RM
    BMC Med Genomics; 2015 Jun; 8():28. PubMed ID: 26059414
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Yin Yang 1-mediated epigenetic silencing of tumour-suppressive microRNAs activates nuclear factor-κB in hepatocellular carcinoma.
    Tsang DP; Wu WK; Kang W; Lee YY; Wu F; Yu Z; Xiong L; Chan AW; Tong JH; Yang W; Li MS; Lau SS; Li X; Lee SD; Yang Y; Lai PB; Yu DY; Xu G; Lo KW; Chan MT; Wang H; Lee TL; Yu J; Wong N; Yip KY; To KF; Cheng AS
    J Pathol; 2016 Apr; 238(5):651-64. PubMed ID: 26800240
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Integrated exome sequencing and microarray analyses detected genetic defects and underlying pathways of hepatocellular carcinoma.
    Chong ML; Knight J; Peng G; Ji W; Chai H; Lu Y; Wu S; Li P; Hu Q
    Cancer Genet; 2023 Aug; 276-277():30-35. PubMed ID: 37418972
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 121.